- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05960474
Coronary Microvascular Disease (CMD) Registry
July 17, 2023 updated by: Medstar Health Research Institute
The purpose of this project is to provide appropriate administrative and technical supports for the warehousing and use of a database of patients with coronary microvascular disease (CMD).
This protocol will outline the process for identification and capture of data, storage, as well as data use and sharing internally and externally for research purposes.
Study Overview
Status
Recruiting
Conditions
Intervention / Treatment
Study Type
Observational
Enrollment (Estimated)
1000
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Megan Rowland
- Phone Number: 202-877-2959
- Email: megan.e.rowland@medstar.net
Study Locations
-
-
District of Columbia
-
Washington, District of Columbia, United States, 20010
- Recruiting
- Medstar Washington Hospital Center
-
Contact:
- Megan Rowland
- Phone Number: 202-877-2959
- Email: megan.e.rowland@medstar.net
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
N/A
Sampling Method
Non-Probability Sample
Study Population
Subjects to be enrolled in either objective for this registry includes patients, 18 years or older, with coronary microvascular disease.
Description
Inclusion Criteria:
- Those with Coronary Microvascular Disease
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Establish a Registry of CMD patients
Time Frame: 10 years
|
10 years
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
February 1, 2023
Primary Completion (Estimated)
January 1, 2033
Study Completion (Estimated)
January 1, 2033
Study Registration Dates
First Submitted
July 17, 2023
First Submitted That Met QC Criteria
July 17, 2023
First Posted (Actual)
July 25, 2023
Study Record Updates
Last Update Posted (Actual)
July 25, 2023
Last Update Submitted That Met QC Criteria
July 17, 2023
Last Verified
May 1, 2023
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- STUDY00004429
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Coronary Microvascular Dysfunction
-
Cedars-Sinai Medical CenterActive, not recruitingMicrovascular Coronary DysfunctionUnited States
-
Peking University First HospitalRecruitingCoronary Microvascular DysfunctionChina
-
Amir LermanCompletedCoronary Microvascular DysfunctionUnited States
-
Ge JunboRainMed MedicalCompleted
-
Mette ZanderHvidovre University HospitalCompletedCoronary Microvascular DysfunctionDenmark
-
Lisata Therapeutics, Inc.TerminatedCoronary Microvascular Disease | Coronary Microvascular Dysfunction | Microvascular Coronary Artery DiseaseUnited States
-
Cedars-Sinai Medical CenterWithdrawnMicrovascular Coronary DysfunctionUnited States
-
Istanbul UniversityCompletedIschemic Heart Disease | Coronary Microvascular Disease | Microvascular Angina | Coronary Microvascular Dysfunction | Non-Obstructive Coronary Atherosclerosis | Microvascular Coronary Artery DiseaseTurkey
-
Spanish Society of CardiologyRecruitingAngina, Stable | Coronary Microvascular Disease | Coronary Microvascular DysfunctionSpain
-
Karolinska InstitutetAbbottCompletedCoronary Artery Disease | Microvascular Angina | Coronary Microvascular DysfunctionSweden
Clinical Trials on Outcomes for Patients with CMD
-
Institut de Sante Parasport Connecte SynergiesAssistance Publique - Hôpitaux de ParisRecruitingDisability or Chronic Disease Leading to DisablementFrance
-
Landeskrankenanstalten-BetriebsgesellschaftEuropean CommissionCompletedPulmonary Disease, Chronic Obstructive (COPD)Austria
-
Regione VenetoAzienda Ospedaliera Universitaria Integrata Verona; Azienda Ospedaliera di... and other collaboratorsCompleted
-
University of Milano BicoccaCompleted
-
Hospices Civils de LyonCompletedUlcer | Anemia | Sickle Cell DiseaseFrance
-
Landeskrankenanstalten-BetriebsgesellschaftEuropean CommissionCompletedDiabetes Mellitus Type 2Austria
-
Duke UniversityMedtronicCompletedVentricular Fibrillation | Tachycardia, VentricularUnited States
-
Norwegian Centre for Ageing and HealthThe Research Council of NorwayCompleted
-
Istituto Ortopedico RizzoliRecruitingKnee Osteoarthritis | FibromyalgiaItaly
-
Regione VenetoAzienda Ospedaliera Universitaria Integrata Verona; Azienda Ospedaliera di... and other collaboratorsCompleted